In the post-pandemic era, vaccination for all kinds of diseases has become a hot-button issue, increasingly so with the confirmation ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Each year, when temperatures drop and gatherings move indoors, we enter respiratory virus season. During this time, from ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...

The U.S., including Arizona, is in the midst of a nasty wave of influenza: the first "high severity" U.S. season in seven years, according to the U.S. Centers for Disease Control and Prevention. In ...